Fluxid, Pepcid, Pepcid Ac, Pepcid Rpd (famotidine) is a small molecule pharmaceutical. Famotidine was first approved as Fluxid on 1986-10-15. It is used to treat duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. The pharmaceutical is active against histamine H2 receptor. Pepcid's patent is valid until 2021-08-26 (FDA).
|Trade Name||Fluxid, Pepcid, Pepcid Ac, Pepcid Rpd|
|Indication||duodenal ulcer, dyspepsia, gastroesophageal reflux, heartburn, helicobacter infections, peptic esophagitis, stomach ulcer, urticaria, zollinger-ellison syndrome|
|Drug Class||H2-receptor antagonists (cimetidine type)|